MINNEAPOLIS, March 3, 2020 /PRNewswire/ -- People with mild traumatic brain injury who are exposed to early morning blue light therapy may experience a decrease in depression and other concussion symptoms, according to a preliminary study released today that will be presented at the

CRANBERRY TOWNSHIP, Pa., March 3, 2020 /PRNewswire/ -- PHOENIX Rehabilitation & Health Services ("

SAN FRANCISCO, March 3, 2020 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that Sean George, co foun

YARDLEY, Pa., March 3, 2020 /PRNewswire/ -- Intraprise Health, one of HITRUST's longest tenured external assessors and a leading provider of highly rated, healthcare-specific cybersecurity services, today announced that Ryan Patrick, Senior Vice President of Security Products, and Melissa Hawkins, Informa

BOSTON, March 3, 2020 /PRNewswire/ -- Stealth BioThe

HOLLYWOOD, Fla., March 3, 2020 /PRNewswire/ -- DeliverLean CEO Scott Harris is bringing his company's health and wellness mission to the City of Miami in partnership with Mayor Francis Suarez. The Miami Moves Healthiest City Campaign, which Harris presented to Mayor Suarez, was

PALO ALTO, Calif., March 3, 2020 /PRNewswire/ -- Sciton Inc., a leading manufacturer of medical and aesthetic lasers and light source technologies concludes 2019 at an all-time high, promoting key executives, holding two sold out user summits and launching multiple new technologies while enjoying successive years of growth.

STOCKHOLM, March 3, 2020 /PRNewswire/ -- As part of the preparations for a potential offering of American Depository Shares in the United States and a concurrent listing on the Nasdaq Global Market in the United States, the extraordinary general meeting resolved to, in accordance with the board of director

- MOMENTUM Phase 3 clinical trial for momelotinib underway, targeting enrolment of 180 patients with myelofibrosis who are symptomatic and anemic -- Publications highlighting durability, safety and efficacy data for momelotinib planned throughout 2020 -- Company to host analyst conference call at 8 am ET today - VANCOUVER,

CAMBRIDGE, Mass., March 3, 2020 /PRNewswire/ -- Obsidian Therapeutics, a biotechnology company pioneering controllable cell and gene therapies, today announced the appointment of Anders Götzsche to its Board of Directors. Mr. Götzsche will serve as the Chair of Obsidian's Audit Committee. Mr. Götzsche currently serves as the Executive Vice President and Ch